Zeronda Tyler
Insider CIK 1867033 · YARW Interim CFO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| YARW Yarrow Bioscience, Inc. | A Award deriv | 2026-10-29 | 2026-10-30 | 156,115 | — | $0 | 156,115 | SEC↗ |
| YARW Yarrow Bioscience, Inc. | A Award deriv | 2026-07-27 | 2026-07-29 | 185,798 | — | $0 | 185,798 | SEC↗ |
| YARW Yarrow Bioscience, Inc. | A Award deriv | 2026-07-27 | 2026-07-29 | 185,798 | — | $0 | 185,798 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-07-23 | 2026-07-24 | 22,516 | $0.90 | $20.3K | 74,918 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-06-30 | 2026-07-02 | 3,464 | $0.65 | $2.3K | 97,434 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-03-31 | 2026-04-02 | 4,007 | $0.60 | $2.4K | 99,788 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-12-31 | 2026-01-05 | 7,858 | $0.58 | $4.6K | 103,795 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-09-30 | 2025-10-02 | 3,420 | $0.34 | $1.2K | 111,653 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-06-30 | 2025-07-02 | 3,420 | $1.65 | $5.6K | 115,073 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-03-31 | 2025-04-02 | 8,399 | $1.58 | $13.3K | 118,493 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2025-01-21 | 2025-01-23 | 230,000 | — | $0 | 230,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-12-31 | 2025-01-02 | 4,675 | $3.35 | $15.7K | 126,892 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-09-30 | 2024-10-02 | 84 | $1.88 | $158 | 131,567 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-07-01 | 2024-07-03 | 92 | $1.92 | $177 | 131,651 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-04-01 | 2024-04-03 | 94 | $3.08 | $290 | 131,743 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-01-02 | 2024-01-03 | 93 | $2.28 | $212 | 131,837 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 62,500 | — | $0 | 62,500 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2024-01-01 | 2024-01-03 | 62,500 | — | $0 | 131,930 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2023-12-13 | 2023-12-15 | 62,500 | — | $0 | 62,500 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2023-12-13 | 2023-12-15 | 62,500 | — | $0 | 69,430 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-10-02 | 2023-10-04 | 1,087 | $3.83 | $4.2K | 6,930 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-06-30 | 2023-07-05 | 91 | $4.10 | $373 | 8,017 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-03-31 | 2023-04-04 | 384 | $3.08 | $1.2K | 8,108 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-12-31 | 2023-01-04 | 354 | $0.15 | $53 | 173,005 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-09-30 | 2022-10-04 | 353 | $0.22 | $78 | 173,359 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-06-30 | 2022-07-05 | 354 | $0.39 | $138 | 173,712 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2022-05-31 | 2022-06-02 | 12,510 | $0.35 | $4.4K | 174,066 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-03-31 | 2022-04-04 | 773 | $0.65 | $502 | 161,556 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2022-03-17 | 2022-03-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2022-03-17 | 2022-03-18 | 75,000 | — | $0 | 162,329 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-12-31 | 2022-01-04 | 206 | $1.02 | $210 | 87,329 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-11-30 | 2021-12-02 | 4,187 | $0.88 | $3.7K | 87,535 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-09-30 | 2021-10-01 | 206 | $1.39 | $286 | 83,348 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-09-02 | 2021-09-03 | 60,860 | — | $0 | 60,860 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-09-02 | 2021-09-03 | 60,859 | — | $0 | 83,554 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-06-30 | 2021-07-02 | 700 | $3.51 | $2.5K | 22,695 | SEC↗ |